Top

Published in:

01-08-2007 | Review

B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue

Authors: Arne Hansen, Peter E Lipsky, Thomas Dörner

Published in: Arthritis Research & Therapy | Issue 4/2007

Abstract

Primary Sjögren's syndrome (pSS) is an autoimmune disorder characterized by specific pathological features. A hallmark of pSS is B-cell hyperactivity as manifested by the production of autoantibodies, hypergammaglobulinemia, formation of ectopic lymphoid structures within the inflamed tissues, and enhanced risk of B-cell lymphoma. Changes in the distribution of peripheral B-cell subsets and differences in post-recombination processes of immunoglobulin variable region (IgV) gene usage are also characteristic features of pSS. Comparison of B cells from the peripheral blood and salivary glands of patients with pSS with regard to their expression of the chemokine receptors CXCR4 and CXCR5, and their migratory capacity towards the corresponding ligands, CXCL12 and CXCL13, provide a mechanism for the prominent accumulation of CXCR4⁺CXCR5⁺ memory B cells in the inflamed glands. Glandular B cells expressing distinct features of IgV light and heavy chain rearrangements, (re)circulating B cells with increased mutations of cμ transcripts in both CD27^- and CD27⁺ memory B-cell subsets, and enhanced frequencies of individual peripheral B cells containing IgV heavy chain transcripts of multiple isotypes indicate disordered selection and incomplete differentiation processes of B cells in the inflamed tissues in pSS. This may possibly be related to a lack of appropriate censoring mechanisms or different B-cell activation pathways within the ectopic lymphoid structures of the inflamed tissues. These findings add to our understanding of the pathogenesis of this autoimmune inflammatory disorder and may result in new therapeutic approaches.

Available only for authorised users

Fox RI: Sjögren's syndrome. Lancet. 2005, 366: 321-331. 10.1016/S0140-6736(05)66990-5.PubMed

Kassan SS, Moutsopoulos HM: Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med. 2004, 164: 1275-1284. 10.1001/archinte.164.12.1275.PubMed

Hansen A, Lipsky PE, Dörner T: Immunopathogenesis of primary Sjögren's syndrome: implications for disease management and therapy. Curr Opin Rheum. 2005, 17: 558-565. 10.1097/01.bor.0000172801.56744.c3.

Mitsias DI, Kapsogeorgou EK, Moutsopoulos HM: The role of epithelial cells in the initiation and perpetuation of autoimmune lesions: lessons from Sjögren's syndrome (autoimmune epithelitis). Lupus. 2006, 15: 255-261. 10.1191/0961203306lu2290rr.PubMed

Cisholm DM, Mason DK: Labial salivary gland biopsy in Sjögren's disease. J Clin Pathol. 1968, 21: 656-660. 10.1136/jcp.21.5.656.

Daniels TE: Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum. 1984, 27: 147-156. 10.1002/art.1780270205.PubMed

Adamson TC, Fox RI, Frisman DM, Howell FV: Immmunohistologic analysis of lymphoid infiltrates in primary Sjögren's syndrome using monoclonal antibodies. J Immunol. 1983, 130: 203-208.PubMed

Larsson A, Bredberg A, Henriksson G, Manthorpe R, Sallmyr A: Immunohistochemistry of the B-cell component in lower lip salivary glands of Sjögren's syndrome and healthy subjects. Scand J Immunol. 2005, 61: 98-107. 10.1111/j.0300-9475.2005.01540.x.PubMed

Xanthou G, Tapinos NI, Polihronis M, Nezis IP, Margaritis LH, Moutsopoulos HM: CD4 cytotoxic and dendritic cells in the immunopathologic lesion of Sjögren's syndrome. Clin Exp Immunol. 1999, 118: 154-163. 10.1046/j.1365-2249.1999.01037.x.PubMedCentralPubMed

10.

Zeher M, Adany R, Nagy G, Gomez R, Szegedi G: Macrophage containing factor XIII subunit a in salivary glands of patients with Sjögren's syndrome. J Investig Allergol Clin Immunol. 1991, 1: 261-265.PubMed

11.

James JA, Harley JB, Scofield RH: Role of viruses in systemic lupus erythematosus and Sjögren's syndrome. Curr Opin Rheumatol. 2001, 13: 370-376. 10.1097/00002281-200109000-00005.PubMed

12.

Fox RI, Pearson G, Vaughan JH: Detection of Epstein–Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjögren's syndrome. J Immunol. 1986, 137: 3162-3168.PubMed

13.

Nakamura H, Kawakami A, Tominaga M, Hida A, Yamasaki S, Migita K, Kawabe Y, Nakamura T, Eguchi K: Relationship between Sjögren's syndrome and human T-lymphotropic virus type I infection: follow-up study of 83 patients. J Lab Clin Med. 2000, 135: 139-144. 10.1067/mlc.2000.103429.PubMed

14.

Triantafyllopoulou A, Tapinos N, Moutsopoulos HM: Evidence for Coxsackievirus infection in primary Sjögren's syndrome. Arthritis Rheum. 2004, 50: 2897-2902. 10.1002/art.20463.PubMed

15.

Bolstad AI, Jonsson R: Genetic aspects of Sjögren's syndrome. Arthritis Res. 2002, 4: 353-359. 10.1186/ar599.PubMedCentralPubMed

16.

Saegusa K, Ishimaru N, Yanagi K, Mishima K, Arakaki R, Suda T, Saito I, Hayashi Y: Prevention and induction of autoimmune exocrinopathy is dependent on pathogenic autoantigen cleavage in murine Sjögren's syndrome. J Immunol. 2002, 169: 1050-1057.PubMed

17.

Nordmark G, Alm GV, Ronnblom L: Mechanisms of disease: primary Sjögren's syndrome and the type I interferon system. Nat Clin Pract Rheumatol. 2006, 2: 262-269. 10.1038/ncprheum0173.PubMed

18.

Nagata Y, Inoue H, Yamada K, Higashiyama H, Mishima K, Kizu Y, Takeda I, Mizuno F, Hayashi Y, Saito I: Activation of Epstein–Barr virus by saliva from Sjögren's syndrome patients. Immunology. 2004, 111: 223-229. 10.1111/j.0019-2805.2003.01795.x.PubMedCentralPubMed

19.

Hagiwara E, Pando J, Ishigatsubo Y, Klinman DM: Altered frequency of type 1 cytokine secreting cells in the peripheral blood of patients with primary Sjögren's syndrome. J Rheumatol. 1998, 25: 89-93.PubMed

20.

Mitsias DI, Tzioufas AG, Veiopoulou C, Zintzaras E, Tassios IK, Kogopoulou O, Moutsopoulos HM, Thyphronitis G: The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjögren's syndrome. Clin Exp Immunol. 2002, 128: 562-568. 10.1046/j.1365-2249.2002.01869.x.PubMedCentralPubMed

21.

Zintsaras E, Voulgarelis M, Moutsopoulos HM: The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med. 2005, 165: 2337-2344. 10.1001/archinte.165.20.2337.

22.

Bohnhorst J, Bjorgan MB, Thoen JE, Natvig JB, Thompson KM: Bm1-bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjögren's syndrome. J Immunol. 2001, 167: 3610-3618.PubMed

23.

Bohnhorst JO, Bjorgan MB, Thoen JE, Jonsson R, Natvig JB, Thompson KM: Abnormal B cell differentiation in primary Sjögren's syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with serum IgG concentration. Clin Immunol. 2002, 103: 79-88. 10.1006/clim.2002.5199.PubMed

24.

Hansen A, Odendahl M, Reiter K, Jacobi AM, Feist E, Scholze J, Burmester GR, Lipsky PE, Dörner T: Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum. 2002, 46: 2160-2167. 10.1002/art.10445.PubMed

25.

Hansen A, Gosemann M, Pruss A, Reiter K, Ruzickova S, Lipsky PE, Dörner T: Abnormalities in peripheral B cell memory of patients with primary Sjögren's syndrome. Arthritis Rheum. 2004, 50: 1897-1908. 10.1002/art.20276.PubMed

26.

Hansen A, Reiter K, Ziprian T, Jacobi A, Hoffmann A, Gosemann M, Scholze J, Lipsky PE, Dörner T: Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjögren's syndrome. Arthritis Rheum. 2005, 52: 2109-2119. 10.1002/art.21129.PubMed

27.

Stott DI, Hiepe F, Hummel M, Steinhauser G, Berek C: Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjögren's syndrome. J Clin Invest. 1998, 102: 938-946.PubMedCentralPubMed

28.

Amft N, Curnow SJ, Scheel-Toellner D, Devadas A, Oates J, Crocker J, Hamburger J, Ainsworth J, Mathews J, Salmon M, et al: Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome. Arthritis Rheum. 2001, 44: 2633-2641. 10.1002/1529-0131(200111)44:11<2633::AID-ART443>3.0.CO;2-9.PubMed

29.

Xanthou G, Polihronis M, Tzioufas AG, Paikos S, Sideras P, Moutsopoulos HM: 'Lymphoid' chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients. Possible participation in lymphoid structure formation. Arthritis Rheum. 2001, 44: 408-418. 10.1002/1529-0131(200102)44:2<408::AID-ANR60>3.0.CO;2-0.PubMed

30.

Salomonsson S, Larsson P, Tengnér P, Mellquist E, Hjelmström P, Wahren-Herlenius M: Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome. Scand J Immunol. 2002, 55: 336-342. 10.1046/j.1365-3083.2002.01058.x.PubMed

31.

Barone F, Bombardieri M, Manzo A, Blades MC, Morgan PR, Challacombe SJ, Valesini G, Pitzalis C: Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome. Arthritis Rheum. 2005, 52: 1773-1784. 10.1002/art.21062.PubMed

32.

Salomonsson S, Jonsson MV, Skarstein K, Brokstad KA, Hjelmström P, Wahren-Herlenius M, Jonsson R: Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum. 2003, 48: 3187-3201. 10.1002/art.11311.PubMed

33.

Jonsson MV, Szodoray P, Jellestad S, Jonsson R, Skarstein K: Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjögren's syndrome. J Clin Immunol. 2005, 25: 189-201. 10.1007/s10875-005-4091-5.PubMed

34.

Szodoray P, Alex P, Jonsson MV, Knowlton N, Dozmorov I, Nakken B, Delaleu N, Jonsson R, Centola M: Distinct profiles of Sjögren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF. Clin Immunol. 2005, 117: 168-176. 10.1016/j.clim.2005.06.016.PubMed

35.

Daridon C, Pers JO, Devauchelle V, Martins-Cavalho C, Hutin P, Pennec YL, Saraux A, Youinouh P: Identification of transitional type II B cells in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum. 2006, 54: 2280-2288. 10.1002/art.21936.PubMed

36.

Schröder AE, Greiner A, Seyfert C, Berek C: Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc Natl Acad Sci USA. 1996, 93: 221-225. 10.1073/pnas.93.1.221.PubMedCentralPubMed

37.

Hutloff A, Buchner K, Reiter K, Baelde HJ, Odendahl M, Jacobi A, Dörner T, Kroczek RA: Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus. Arthritis Rheum. 2004, 50: 3211-3220. 10.1002/art.20519.PubMed

38.

Hsi ED, Singleton TP, Svoboda SM, Schnitzer B, Ross CW: Characterization of the lymphoid infiltrate in Hashimoto thyroiditis by immunohistochemistry and polymerase chain reaction for immunoglobulin heavy chain rearrangement. Am J Clin Pathol. 1998, 110: 327-333.PubMed

39.

Ansell SM, Grant CS, Habermann TM: Primary thyroid lymphoma. Semin Oncol. 1999, 26: 316-323.PubMed

40.

Kordossis T, Paikos S, Aroni K, Kitsanta P, Dimitrakopoulos A, Kavouklis E, Alevizou V, Kyriaki P, Skopouli FN, Moutsopoulos HM: Prevalence of Sjögren's-like syndrome in a cohort of HIV-1-positive patients: descriptive pathology and immunopathology. Br J Rheumatol. 1998, 37: 691-695. 10.1093/rheumatology/37.6.691.PubMed

41.

Widney D, Gundapp G, Said JW, van der Meijden M, Bonavida B, Demidem A, Trevisan C, Taylor J, Detels R, Martinez-Maza O: Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma. Clin Immunol. 1999, 93: 114-123. 10.1006/clim.1999.4782.PubMed

42.

Scott CA, Avellini C, Desinan L, Pirisi M, Ferraccioli GF, Bardus P, Fabris C, Casatta L, Bartoli E, Beltrami CA: Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: comparison of Sjögren's syndrome. Histopathology. 1997, 30: 41-48. 10.1046/j.1365-2559.1997.d01-561.x.PubMed

43.

Arcaini L, Burcheri S, Rossi A, Paulli M, Bruno R, Passamonti F, Brusamolino E, Molteni A, Pulsoni A, Cox MC, et al: Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT. Ann Oncol. 2007, 18: 346-350. 10.1093/annonc/mdl388.PubMed

44.

Maszzuccheli L, Blaser A, Kappeler A, Scharli P, Laissue JA, Baggiolini M, Uguccioni M: BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J Clin Invest. 1999, 104: R49-R54.

45.

Fox RI, Saito I: Criteria for diagnosis of Sjögren's syndrome. Rheum Dis Clin North Am. 1994, 20: 391-407.PubMed

46.

Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, the European Study Group on Classification Criteria for Sjögren's Syndrome, et al: Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American–European consensus group. Ann Rheum Dis. 2002, 61: 554-558. 10.1136/ard.61.6.554.PubMedCentralPubMed

47.

Dawson LJ, Stanbury J, Venn N, Hasdimir B, Rogers SN, Smith PM: Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum. 2006, 54: 1165-1173. 10.1002/art.21764.PubMed

48.

Jonsson MV, Delaleu N, Brokstad KA, Berggreen E, Skarstein K: Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland. Arthritis Rheum. 2006, 54: 2300-2305. 10.1002/art.21945.PubMed

49.

Tsunawaki S, Nakamura S, Ohyama Y, Sasaki M, Ikebe-Hiroki A, Hiraki A, Kadena T, Kawamura W, Shinohara M, Shirasuna K: Possible function of salivary gland epithelial cells as nonprofessional antigen-presenting cells in the development of Sjögren's syndrome. J Rheumatol. 2002, 29: 1884-1896.PubMed

50.

Vogelsang P, Jonsson MV, Dalvin ST, Appel S: Role of dendritic cells in Sjögren's syndrome. Scand J Immunol. 2006, 64: 219-226. 10.1111/j.1365-3083.2006.01811.x.PubMed

51.

Dimitrou ID, Kapsogeorgou EK, Moutsopoulos HM, Manoussakis MN: CD40 on salivary gland epithelial cells: high constitutive expression by cultured cells from Sjögren's syndrome patients indicating their intrinsic activation. Clin Exp Immunol. 2002, 127: 386-392. 10.1046/j.1365-2249.2002.01752.x.

52.

Ohlsson M, Szodoray P, Loro LL, Johanessen AC, Jonsson R: CD40, CD154, Bax and Bcl-2 expression in Sjögren's syndrome salivary glands: a putative anti-apoptotic role during its effector phases. Scand J Immunol. 2002, 56: 561-571. 10.1046/j.1365-3083.2002.01168.x.PubMed

53.

Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, Tschopp J, Cachero TG, Batten M, Wheway J, et al: Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. J Clin Invest. 2002, 109: 59-68. 10.1172/JCI200214121.PubMedCentralPubMed

54.

Ittah M, Miceli-Richard C, Gottenberg JE, Lavie F, Lazure T, Ba N, Sellam J, Lepajolec C, Mariette X: B-cell activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome. Arthritis Res Ther. 2006, 8: R51-10.1186/ar1912.PubMedCentralPubMed

55.

Lavie F, Miceli-Richard C, Quillard J, Roux S, Leclerc P, Mariette X: Expression of BAFF (BLys) in T cell infiltrating labial salivary glands from patients with Sjögren's syndrome. J Pathol. 2004, 202: 496-502. 10.1002/path.1533.PubMed

56.

Kelsoe G: Life and death in germinal centers (Redux). Immunity. 1996, 4: 107-111. 10.1016/S1074-7613(00)80675-5.PubMed

57.

Nanki T, Hayashida K, El-Gabalawy HS, Suson S, Shi K, Girschick HJ, Yavuz S, Lipsky PE: Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J Immunol. 2000, 165: 6590-6598.PubMed

58.

Shi K, Hayashida K, Kaneko M, Hashimoto J, Tomita T, Lipsky PE, Yoshikawa H, Ochi T: Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients. J Immunol. 2001, 166: 650-655.PubMed

59.

Weyand CM, Kurtin PJ, Goronzy JJ: Ectopic lymphoid organogenesis. A fast track for autoimmunity. Am J Pathol. 2001, 159: 787-793.PubMedCentralPubMed

60.

Cupedo T, Mebius RE: Role of chemokines in the development of secondary and tertiary lymphoid tissues. Semin Immunol. 2003, 15: 243-248. 10.1016/j.smim.2003.08.002.PubMed

61.

Manthorpe R, Benoni C, Jacobsson L, Kirtava Z, Larsson A, Riedholm R, Nyhagen C, Tabery H, Theander E: Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?. Ann Rheum Dis. 2000, 59: 54-60. 10.1136/ard.59.1.54.PubMedCentralPubMed

62.

Wise CM, Woodruff RD: Minor salivary gland biopsies in patients investigated for primary Sjögren's syndrome. A review of 187 patients. J Rheumatol. 1993, 20: 1515-1518.PubMed

63.

Hyjek E, Smith WJ, Isaacson PG: Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis. Hum Pathol. 1988, 19: 766-776. 10.1016/S0046-8177(88)80259-4.PubMed

64.

Jaffe ES: Lymphoid lesions of the head and neck: a model of lymphocyte homing and lymphomagenesis. Mod Pathol. 2002, 15: 255-263. 10.1038/modpathol.3880521.PubMed

65.

Ioannidis JP, Vassiliou VA, Moutsopoulos HM: Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum. 2002, 46: 741-747. 10.1002/art.10221.PubMed

66.

Xu KP, Katagiri S, Takeuchi T, Tsubota K: Biopsy of labial salivary glands and lacrimal glands in the diagnosis of Sjögren's syndrome. J Rheumatol. 1997, 23: 76-82.

67.

Pijpe J, Kalk WW, van der Wal JE, Vissink A, Kluin PM, Roodenburg JL, Bootsma H, Kallenberg CG, Spijkervert FK: Parotid gland biopsy compared to labial biopsy in the diagnosis of patients with primary Sjögren's syndrome. Rheumatology.

68.

Dörner T, Lipsky PE: Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndrome. Arthritis Res. 2002, 4: 360-371. 10.1186/ar603.PubMedCentralPubMed

69.

Potter KN, Mockridge CI, Rahman A, Buchan S, Hamblin T, Davidson B, Isenberg DA, Stevenson FK: Disturbances in peripheral blood B cell subpopulations in autoimmune patients. Lupus. 2002, 11: 872-877. 10.1191/0961203302lu309oa.PubMed

70.

Klein U, Rajewsky K, Küppers R: Human immunoglobulin (Ig)M⁺IgD⁺ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med. 1998, 188: 1679-1689. 10.1084/jem.188.9.1679.PubMedCentralPubMed

71.

Agematsu K, Nagumo H, Yang FC, Nakazawa T, Fukushima K, Ito S, Sugita K, Mori T, Kobata T, Morimoto C: B cell subpopulations separated by CD27 and crucial collaboration of CD27⁺ B cells and helper T cells in immunoglobulin production. Eur J Immunol. 1997, 27: 2073-2079. 10.1002/eji.1830270835.PubMed

72.

Shinozaki K, Yasui K, Agematsu K: Direct B/B-cell interactions in immunoglobulin synthesis. Clin Exp Immunol. 2001, 124: 386-391. 10.1046/j.1365-2249.2001.01518.x.PubMedCentralPubMed

73.

Nagumo H, Agematsu K, Kobayashi N, Shinozaki K, Hokibara S, Nagase H, Takamoto M, Yasui K, Sugane K, Komiyama A: The different process of class switching and somatic hypermutation; a novel analysis by CD27^- naive B cells. Blood. 2002, 99: 567-575. 10.1182/blood.V99.2.567.PubMed

74.

Odendahl M, Mei H, Hoyer BF, Jacobi AM, Hansen A, Radbruch A, Dörner T: Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood. 2005, 105: 1614-1621. 10.1182/blood-2004-07-2507.PubMed

75.

Odendahl M, Jacobi A, Hansen A, Feist E, Hiepe F, Burmester GR, Lipsky PE, Radbruch A, Dörner T: Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol. 2000, 165: 5970-5979.PubMed

76.

Jacobi AM, Odendahl M, Reiter K, Bruns A, Burmester GR, Radbruch A, Valet G, Lipsky PE, Dörner T: Correlation between circulating CD27^high plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 2003, 48: 1332-1342. 10.1002/art.10949.PubMed

77.

Mandl T, Bredberg A, Jacobsson LT, Manthorpe R, Henriksson G: CD4+ lymphopenia – a frequent finding in anti-SSA antibody seropositive patients with primary Sjögren's syndrome. J Rheumatol. 2004, 31: 726-728.PubMed

78.

Gellrich S, Rutz S, Borkowski A, Golembowski S, Gromnica-Ihle E, Sterry W, Jahn S: Analysis of V_H-D-J_H gene transcripts in B cells infiltrating the salivary glands and lymph node tissues of patients with Sjögren's syndrome. Arthritis Rheum. 1999, 42: 240-247. 10.1002/1529-0131(199902)42:2<240::AID-ANR5>3.0.CO;2-I.PubMed

79.

Hansen A, Jacobi A, Pruss A, Kaufmann O, Scholze J, Lipsky PE, Dörner T: Comparison of immunoglobulin heavy chain rearrangements between peripheral and glandular B cells in a patient with primary Sjögren's syndrome. Scand J Immunol. 2003, 57: 470-479. 10.1046/j.1365-3083.2003.01226.x.PubMed

80.

Jacobi AM, Hansen A, Kaufmann O, Burmester GR, Lipsky PE, Dörner T: Analysis of immunglobulin light chain rearrangements in the salivary gland and blood of a patient with Sjögren's syndrome. Arthritis Res. 2002, 4: R4-10.1186/ar423.PubMedCentralPubMed

81.

Ansel KM, Ngo VN, Hyman PL, Luther SA, Forster R, Sedgwick JD, Browning JL, Lipp M, Cyster JG: A chemokine-driven feedback loop organizes lymphoid follicles. Nature. 2000, 406: 309-314. 10.1038/35018581.PubMed

82.

Dörner T, Lipsky PE: Signalling pathways in B cells: implications for autoimmunity. Curr Top Microbiol Immunol. 2006, 305: 213-240.PubMed

83.

Horsfall AC, Rose LM, Maini RN: Autoantibodiy synthesis in salivary glands of Sjögren's syndrome patients. J Autoimmun. 1989, 2: 554-568. 10.1016/0896-8411(89)90189-3.

84.

Berra A, Sterin-Borda L, Bacman S, Borda E: Role of salivary IgA in the pathogenesis of Sjögren syndrome. Clin Immunol. 2002, 104: 49-57. 10.1006/clim.2002.5228.PubMed

85.

Rutjes SA, Utz PJ, van der Heijden A, Broekhuis C, van Venrooij WJ, Purin GJM: The La (SS-B) autoantigen, a key protein in RNA biogenesis, is dephosphorylated and cleaved early during apoptosis. Cell Death Differ. 1999, 6: 976-986. 10.1038/sj.cdd.4400571.PubMed

86.

Ohlsson M, Jonsson R, Brokstad KA: Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren's syndrome. Scand J Immunol. 2002, 56: 456-469. 10.1046/j.1365-3083.2002.01072_79.x.PubMed

87.

Espinosa A, Zhou W, Ek M, Hedlund M, Brauner S, Popovic K, Horvath L, Wallerskog T, Mohamed O, Nyberg F, et al: The Sjögren's syndrome-associated autoantigen Ro 52 is an E3 ligase that regulates proliferation and cell death. J Immunol. 2006, 176: 6277-6285.PubMed

88.

Namekawa T, Kuroda K, Kato T, Yamamoto K, Murata H, Sakamaki T, Nishioka K, Iwamoto I, Saitoh Y, Sumida T: Identification of Ro(SSA) 52 kDa reactive T cells in labial salivary glands from patients with Sjögren's syndrome. J Rheumatol. 1995, 22: 2092-2099.PubMed

89.

Tengnér P, Halse AK, Haga HJ, Jonsson R, Wahren-Herlenius M: Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren's syndrome. Arthritis Rheum. 1998, 41: 2238-2248. 10.1002/1529-0131(199812)41:12<2238::AID-ART20>3.0.CO;2-V.PubMed

90.

Weller S, Faili A, Garcia C, Braun MC, Le Deist FF, de Saint Basile GG, Hermine O, Fischer A, Reynaud CA, Weill JC: CD40–CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc Natl Acad Sci USA. 2001, 98: 1166-1170. 10.1073/pnas.98.3.1166.PubMedCentralPubMed

91.

Obukhanych TV, Nussenzweig MC: T-independent type II immune responses generate memory B cells. J Exp Med. 2006, 203: 305-310. 10.1084/jem.20052036.PubMedCentralPubMed

92.

Ng LG, Ng CH, Woehl B, Sutherland AP, Huo J, Xu S, Mackay F, Lam KP: BAFF costimulation of Toll-like receptor-activated B1 cells. Eur J Immunol. 2006, 36: 1837-1846. 10.1002/eji.200635956.PubMed

93.

Dörner T, Egerer K, Feist E, Burmester GR: Rheumatoid factor revisited. Curr Opin Rheumatol. 2004, 16: 246-253. 10.1097/00002281-200405000-00013.PubMed

94.

Deacon EM, Matthews JB, Potts AJ, Hamburger J, Mageed RA, Jefferis R: Expression of rheumatoid factor associated cross-reactive idiotypes by glandular B cells in Sjögren's syndrome. Clin Exp Immunol. 1991, 83: 280-285.PubMedCentralPubMed

95.

Kipps TJ, Tomhave E, Chen PP, Fox RI: Molecular characterization of a major autoantibody-associated cross-reactive idiotype in Sjögren's syndrome. J Immunol. 1989, 142: 4261-4268.PubMed

96.

Miklos JA, Swerdlow SH, Bahler DW: Salivary gland mucosa associated lymphoid tissue lymphoma immunoglobulin VH genes show frequent use of V1-69 with distinctive CDR3 features. Blood. 2000, 95: 3878-3884.PubMed

97.

Martin T, Weber JC, Levallois H, Labouret N, Soley A, Koenig S, Korganow AS, Pasquali JC: Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells. Arthritis Rheum. 2000, 43: 908-916. 10.1002/1529-0131(200004)43:4<908::AID-ANR24>3.0.CO;2-K.PubMed

98.

Hansen A, Reiter K, Pruss A, Loddenkemper C, Kaufmann O, Jacobi AM, Scholze J, Lipsky PE, Dörner T: Dissemination of a Sjögren's syndrome-associated extranodal marginal-zone B cell lymphoma: circulating lymphoma cells and invariant mutational pattern of nodal Ig heavy and light chain variable-region gene rearrangements. Arthritis Rheum. 2006, 54: 127-137. 10.1002/art.21558.PubMed

99.

Tzioufas AG, Boumba DS, Skopouli FN, Moutsopoulos HM: Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome. Arthritis Rheum. 1996, 39: 767-772. 10.1002/art.1780390508.PubMed

100.

Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM, the members of the European Concerted Action on Sjögren's syndrome: Malignant lymphoma in primary Sjögren's syndrome. A multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's syndrome. Arthritis Rheum. 1999, 42: 1765-1772. 10.1002/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V.PubMed

101.

Theander E, Manthorpe R, Jacobsson LTH: Mortality and causes of death in primary Sjögren's syndrome. A prospective cohort study. Arthritis Rheum. 2004, 50: 1262-1269. 10.1002/art.20176.PubMed

102.

Tsuiji M, Yurasov S, Velinzon K, Thomas S, Nussenzweig MC, Wardemann H: A checkpoint for autoreactivity in human IgM⁺ memory B cell development. J Exp Med. 2006, 203: 293-400. 10.1084/jem.20052033.

103.

Sutherland AP, Mackay F, Mackay CR: Targeting BAFF: immunomodulation for autoimmune diseases and lymphomas. Pharmacol Ther. 2006, 112: 774-786. 10.1016/j.pharmthera.2006.06.002.PubMed

104.

Martin F, Dixit VM: Unraveling TACIt functions. Nat Genet. 2005, 37: 793-794. 10.1038/ng0805-793.PubMed

105.

Szodoray P, Jellestad S, Alex P, Zhou T, Wilson PC, Centola M, Brun JG, Jonsson R: Programmed cell death of peripheral blood B cells determined by laser scanning cytometry in Sjögren's syndrome with special emphasis on BAFF. J Clin Immunol. 2004, 24: 600-611. 10.1007/s10875-004-6240-7.PubMed

106.

Mariette X, Roux S, Zhang J, Bengoufa D, Lavie F, Zhou T, Kimberly R: The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome. Ann Rheum Dis. 2003, 62: 168-171. 10.1136/ard.62.2.168.PubMedCentralPubMed

107.

Batten M, Fletcher C, Ng LG, Groom J, Wheway J, Laabi Y, Xin X, Schneider P, Tschopp J, Mackay GR, et al: TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma. J Immunol. 2004, 172: 812-822.PubMed

108.

Manoussakis MN, Tzioufas AG, Pange PJE, Moutsopoulos HM: Serologic profiles in subgroups of patients with Sjögren's syndrome. Scand J Rheumatol. 1986, 61: 89-92.

109.

Radbruch A, Muehlinghaus G, Luger EO, Inamine A, Smith KG, Dörner T, Hiepe F: Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol. 2006, 6: 741-750. 10.1038/nri1886.PubMed

110.

Wahren M, Skarstein K, Blange I, Petterson I, Jonsson R: MRL/lpr mice produce anti-Ro 52,000 MW antibodies: detection, analysis of specificity and site of production. Immunology. 1994, 83: 9-15.PubMedCentralPubMed

111.

Heimbächer C, Hansen A, Pruss A, Jacobi A, Reiter K, Lipsky PE, Dörner T: Immunoglobulin Vκ light chain analysis in patients with Sjögren's syndrome. Arthritis Rheum. 2001, 44: 626-637. 10.1002/1529-0131(200103)44:3<626::AID-ANR111>3.0.CO;2-T.PubMed

112.

Kaschner S, Hansen A, Jacobi A, Reiter K, Monson NL, Odendahl M, Burmester GR, Lipsky PE, Dörner T: Immunoglobulin Vλ light chain gene usage in patients with Sjögren's syndrome. Arthritis Rheum. 2001, 44: 2620-2632. 10.1002/1529-0131(200111)44:11<2620::AID-ART442>3.0.CO;2-M.PubMed

113.

Du M, Diss TC, Xu C, Peng H, Isaacson PG, Pan L: Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in clonal expansion. Leukemia. 1996, 10: 1190-1197.PubMed

114.

Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T: Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 2000, 102: 553-563. 10.1016/S0092-8674(00)00078-7.PubMed

115.

Bertorello R, Cordone MP, Contini P, Rossi P, Indiveri F, Puppo F, Cordone G: Increased levels of interleukin-10 in saliva of Sjögren's syndrome patients. Correlation with disease activity. Clin Exp Med. 2004, 4: 148-151. 10.1007/s10238-004-0049-9.PubMed

116.

Steinfeld SD, Tant L, Burmester GR, Teoh NK, Wegener WA, Goldenberg DM, Pradier O: Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study. Arthritis Res Ther. 2006, 8: R129-10.1186/ar2018.PubMedCentralPubMed

117.

Pijpe J, van Imhoff GW, Spijkervet FK, Roodenburg JL, Wolbink GJ, Mansour K, Vissink A, Kallenberg CG, Bootsma H: Rituximab treatment in patients with Sjögren's syndrome: an open-label phase II study. Arthritis Rheum. 2005, 52: 2740-2750. 10.1002/art.21260.PubMed

Title: B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue
Authors: Arne Hansen
Peter E Lipsky
Thomas Dörner
Publication date: 01-08-2007
Publisher: BioMed Central
Published in: Arthritis Research & Therapy / Issue 4/2007
Electronic ISSN: 1478-6362
DOI: https://doi.org/10.1186/ar2210

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2007

Human meniscus cells express hypoxia inducible factor-1α and increased SOX9 in response to low oxygen tension in cell aggregate culture

Glucosamine prevents in vitro collagen degradation in chondrocytes by inhibiting advanced lipoxidation reactions and protein oxidation

Dysautonomia, fibromyalgia and reflex dystrophy

Falling into TRAPS – receptor misfolding in the TNF receptor 1-associated periodic fever syndrome

Tumour necrosis factor blockade and the risk of osteoporosis: back to the future

Glycosaminoglycan profiles of repair tissue formed following autologous chondrocyte implantation differ from control cartilage

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page